Int J Thyroidol.  2021 May;14(1):46-49. 10.11106/ijt.2021.14.1.46.

Spurious Thyroid Function Test Results due to Biotin Interference: a Report of Three Cases and a Literature Review

• Park JY
• Choi W
• Yoon JH
• Kang HC

• KMID: 2516165
• DOI: http://doi.org/10.11106/ijt.2021.14.1.46

Abstract

Biotin (vitamin B7) is a water-soluble vitamin used as a co-enzyme for carboxylases essential for human metabolism. The high affinity to streptavidin makes biotin an important substance in immunoassays. Excessive biotin intake due to over-the counter supplements has become problematic because of the effects on laboratory test results. There have been no reports of biotin-induced thyroid immunoassay interference in Korea. We report three patients with papillary thyroid cancer who showed false thyrotoxicosis on follow-up laboratory examinations with a literature review. The patients’ medical history should be thoroughly questioned and patients should be informed to curtail consuming biotin before laboratory tests to avoid assay interference. Non-biotinylated assays can be considered if it is impossible to withhold the supplements. These methods will prevent physicians from making incorrect decisions that could result in an inappropriate treatment for their patients.

Keyword

Biotin; Interference; Immunoassay; Thyroid function tests

Reference

References

1. Zempleni J, Wijeratne SS, Hassan YI. 2009; Biotin. Biofactors. 35(1):36–46. DOI: 10.1002/biof.8. PMID: 19319844. PMCID: PMC4757853.

2. Yates AA, Schlicker SA, Suitor CW. 1998; Dietary reference intakes: the new basis for recommendations for calcium and related nutrients, B vitamins, and choline. J Am Diet Assoc. 98(6):699–706. DOI: 10.1016/S0002-8223(98)00160-6. PMID: 9627630.

3. Sasaki Y, Sone H, Kamiyama S, Shimizu M, Shirakawa H, Kagawa Y, et al. 2012; Administration of biotin prevents the develop-ment of insulin resistance in the skeletal muscles of Otsuka Long-Evans Tokushima Fatty rats. Food Funct. 3(4):414–9. DOI: 10.1039/c2fo10175k. PMID: 22218395.

4. Koutsikos D, Agroyannis B, Tzanatos-Exarchou H. 1990; Biotin for diabetic peripheral neuropathy. Biomed Pharmacother. 44(10):511–4. DOI: 10.1016/0753-3322(90)90171-5. PMID: 2085665.

5. Tourbah A, Lebrun-Frenay C, Edan G, Clanet M, Papeix C, Vukusic S, et al. 2016; MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: a randomised, double-blind, placebo-controlled study. Mult Scler. 22(13):1719–31. DOI: 10.1177/1352458516667568. PMID: 27589059. PMCID: PMC5098693.

6. Dundas CM, Demonte D, Park S. 2013; Streptavidin-biotin technology: improvements and innovations in chemical and biological applications. Appl Microbiol Biotechnol. 97(21):9343–53. DOI: 10.1007/s00253-013-5232-z. PMID: 24057405.

7. Li D, Radulescu A, Shrestha RT, Root M, Karger AB, Killeen AA, et al. 2017; Association of biotin ingestion with performance of hormone and nonhormone assays in healthy adults. JAMA. 318(12):1150–60. DOI: 10.1001/jama.2017.13705. PMID: 28973622. PMCID: PMC5818818.

8. Elston MS, Sehgal S, Du Toit S, Yarndley T, Conaglen JV. 2016; Factitious Graves' disease due to biotin immunoassay interference-a case and review of the literature. J Clin Endocrinol Metab. 101(9):3251–5. DOI: 10.1210/jc.2016-1971. PMID: 27362288.

9. Wijeratne NG, Doery JC, Lu ZX. 2012; Positive and negative interference in immunoassays following biotin ingestion: a pharmacokinetic study. Pathology. 44(7):674–5. DOI: 10.1097/PAT.0b013e32835a3c17. PMID: 23089740.

10. Yoshii K, Hosomi K, Sawane K, Kunisawa J. 2019; Metabolism of dietary and microbial vitamin B family in the regulation of host immunity. Front Nutr. 6:48. DOI: 10.3389/fnut.2019.00048. PMID: 31058161. PMCID: PMC6478888.

11. Shigemasa C, Abe K, Taniguchi S, Mitani Y, Ueda Y, Adachi T, et al. 1987; Lower serum free thyroxine (T4) levels in painless thyroiditis compared with Graves' disease despite similar serum total T4 levels. J Clin Endocrinol Metab. 65(2):359–63. DOI: 10.1210/jcem-65-2-359. PMID: 3110204.

12. Hayakawa K, Katsumata N, Hirano M, Yoshikawa K, Ogata T, Tanaka T, et al. 2008; Determination of biotin (vitamin H) by the high-performance affinity chromatography with a trypsin- treated avidin-bound column. J Chromatogr B Analyt Technol Biomed Life Sci. 869(1-2):93–100. DOI: 10.1016/j.jchromb.2008.05.016. PMID: 18514598.

13. Piketty ML, Prie D, Sedel F, Bernard D, Hercend C, Chanson P, et al. 2017; High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference. Clin Chem Lab Med. 55(6):817–25. DOI: 10.1515/cclm-2016-1183. PMID: 28222020.

14. Li D, Ferguson A, Cervinski MA, Lynch KL, Kyle PB. 2020; AACC guidance document on biotin interference in laboratory tests. J Appl Lab Med. 5(3):575–87. DOI: 10.1093/jalm/jfz010. PMID: 32445355.

15. Barbesino G. 2016; Misdiagnosis of Graves' disease with apparent severe hyperthyroidism in a patient taking biotin megadoses. Thyroid. 26(6):860–3. DOI: 10.1089/thy.2015.0664. PMID: 27043844.

16. Koehler VF, Mann U, Nassour A, Mann WA. 2018; Fake news? Biotin interference in thyroid immunoassays. Clin Chim Acta. 484:320–2. DOI: 10.1016/j.cca.2018.05.053. PMID: 29856977.

17. Odhaib SA, Mansour AA, Haddad NS. 2019; How biotin induces misleading results in thyroid bioassays: case series. Cureus. 11(5):e4727. DOI: 10.7759/cureus.4727. PMID: 31363424. PMCID: PMC6663274.

18. Al-Salameh A, Becquemont L, Brailly-Tabard S, Aubourg P, Chanson P. 2017; A somewhat bizarre case of Graves disease due to vitamin treatment. J Endocr Soc. 1(5):431–5. DOI: 10.1210/js.2017-00054. PMID: 29264498. PMCID: PMC5686664.

19. Ardabilygazir A, Afshariyamchlou S, Mir D, Sachmechi I. 2018; Effect of high-dose biotin on thyroid function tests: case report and literature review. Cureus. 10(6):e2845. DOI: 10.7759/cureus.2845. PMID: 30140596. PMCID: PMC6103391.